Tag: pharmaceutical supply chain

Quality concerns: when clinicians question generic manufacturing

Posted by: Lesley Williams in: Prescription Drugs

19 Dec | 11:43 AM

Clinicians are raising alarms about generic drug quality as manufacturing shifts overseas. Studies show higher adverse event rates for drugs made in India, and outdated supply chains are causing dangerous shortages. Transparency and domestic production may be the key to safer generics.

Refill-By Dates vs. Expiration Dates on Prescription Labels: A Clear Guide

Confused by the dates on your medicine bottle? Learn the critical difference between Expiration Dates and Refill-By Dates to ensure safety and avoid treatment gaps.

Trade agreements and generics: TRIPS and patent policy explained

Explore how the TRIPS agreement shapes generic medicine access globally. Learn about patent laws, compulsory licensing, and the balance between innovation and public health.

Contamination Controls: Preventing Adulteration in Generic Drugs

Contamination controls in generic drug manufacturing prevent dangerous cross-contamination and ensure patient safety. Learn how cleanrooms, real-time monitoring, and human protocols keep generics safe-and why regulators are cracking down.

Managing Therapeutic Equivalents in Combination Drugs: Dose Considerations and Practical Risks

Managing therapeutic equivalence in combination drugs requires more than matching active ingredients. Dose interactions, formulation differences, and NTI risks can lead to serious errors-even when generics are FDA-approved.

Switching Health Plans? How Generic Drug Coverage Can Save You Hundreds

Switching health plans? Your generic drug costs could spike if you don't check formulary tiers. Learn how tier structures, deductibles, and state rules affect what you pay-and how to avoid costly surprises.

Tag: pharmaceutical supply chain

Quality concerns: when clinicians question generic manufacturing

recent posts

categories

archives

tags